miR-137 suppresses tumor growth of malignant melanoma by targeting aurora kinase A

被引:23
作者
Chang, Xiao [1 ]
Zhang, Haiping [1 ]
Lian, Shi [2 ]
Zhu, Wei [1 ]
机构
[1] Capital Med Univ, Xuanwu Hosp, Dept Dermatol & Venereal Dis, 45 Changchun St, Beijing 100053, Peoples R China
[2] Capital Med Univ, Dept Dermatol & Venereal Dis, Beijing 100069, Peoples R China
关键词
miR-137; Malignant melanoma; Aurora kinase A; Cell growth; MEK INHIBITORS; CHROMOSOMAL INSTABILITY; BREAST-CANCER; A KINASE; EXPRESSION; SURVIVAL; MLN8237; CELLS; AURKA; GENE;
D O I
10.1016/j.bbrc.2016.05.090
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
As an oncogene, aurora kinase A (AURKA) is overexpressed in various types of human cancers. However, the expression and roles of AURKA in malignant melanoma are largely unknown. In this study, a miR-137-AURKA axis was revealed to regulate melanoma growth. We found a significant increase in levels of AURKA in melanoma. Both genetic knockdown and pharmacologic inhibition of AURKA decreased tumor cell growth in vitro and in vivo. Further found that miR-137 reduced AURKA expression through interaction with its 3' untranslated region (3'UTR) and that miR-137 was negatively correlated with AURKA expression in melanoma specimens. Overexpression of miR-137 decreased cell proliferation and colony formation in vitro. Notably, re-expression of AURKA significantly rescued miR-137-mediated suppression of cell growth and clonality. In summary, these results reveal that miR-137 functions as a tumor suppressor by targeting AURKA, providing new insights into investigation of therapeutic strategies against malignant melanoma. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:251 / 256
页数:6
相关论文
共 21 条
[1]
The functions of animal microRNAs [J].
Ambros, V .
NATURE, 2004, 431 (7006) :350-355
[2]
Aurora-A Expression Is Independently Associated with Chromosomal Instability in Colorectal Cancer [J].
Baba, Yoshifumi ;
Nosho, Katsuhiko ;
Shima, Kaori ;
Irahara, Natsumi ;
Kure, Shoko ;
Toyoda, Saori ;
Kirkner, Gregory J. ;
Goel, Ajay ;
Fuchs, Charles ;
Ogino, Shuji .
NEOPLASIA, 2009, 11 (05) :418-425
[3]
MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma [J].
Boll, K. ;
Reiche, K. ;
Kasack, K. ;
Moerbt, N. ;
Kretzschmar, A. K. ;
Tomm, J. M. ;
Verhaegh, G. ;
Schalken, J. ;
von Bergen, M. ;
Horn, F. ;
Hackermueller, J. .
ONCOGENE, 2013, 32 (03) :277-285
[4]
AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment [J].
Caputo, Emilia ;
Miceli, Roberta ;
Motti, Maria Letizia ;
Tate, Rosarita ;
Fratangelo, Federica ;
Botti, Gerardo ;
Mozzillo, Nicola ;
Carriero, Maria Vincenza ;
Cavalcanti, Ernesta ;
Palmieri, Giuseppe ;
Ciliberto, Gennaro ;
Pirozzi, Giuseppe ;
Ascierto, Paolo Antonio .
JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
[5]
miR-203 inhibits melanoma invasive and proliferative abilities by targeting the polycomb group gene BMI1 [J].
Chang, Xiao ;
Sun, Yong ;
Han, Siqi ;
Zhu, Wei ;
Zhang, Haiping ;
Lian, Shi .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 456 (01) :361-366
[6]
The mitotic kinase Aurora-A promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα+ breast cancer cells [J].
D'Assoro, A. B. ;
Liu, T. ;
Quatraro, C. ;
Amato, A. ;
Opyrchal, M. ;
Leontovich, A. ;
Ikeda, Y. ;
Ohmine, S. ;
Lingle, W. ;
Suman, V. ;
Ecsedy, J. ;
Iankov, I. ;
Di Leonardo, A. ;
Ayers-Ringler, J. ;
Degnim, A. ;
Billadeau, D. ;
McCubrey, J. ;
Ingle, J. ;
Salisbury, J. L. ;
Galanis, E. .
ONCOGENE, 2014, 33 (05) :599-610
[7]
Aurora-A Kinase as a Promising Therapeutic Target in Cancer [J].
D'Assoro, Antonino B. ;
Haddad, Tufia ;
Galanis, Evanthia .
FRONTIERS IN ONCOLOGY, 2016, 5
[8]
Phase I Study of Aurora A Kinase Inhibitor MLN8237 in Advanced Solid Tumors: Safety, Pharmacokinetics, Pharmacodynamics, and Bioavailability of Two Oral Formulations [J].
Dees, E. Claire ;
Cohen, Roger B. ;
von Mehren, Margaret ;
Stinchcombe, Thomas E. ;
Liu, Hua ;
Venkatakrishnan, Karthik ;
Manfredi, Mark ;
Fingert, Howard ;
Burris, Howard A., III ;
Infante, Jeffrey R. .
CLINICAL CANCER RESEARCH, 2012, 18 (17) :4775-4784
[9]
Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy [J].
Eroglu, Zeynep ;
Ribas, Antoni .
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2016, 8 (01) :48-56
[10]
Anovel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma [J].
Goerguen, Guellue ;
Calabrese, Elisabetta ;
Hideshima, Teru ;
Ecsedy, Jeffrey ;
Perrone, Giulia ;
Mani, Mala ;
Ikeda, Hiroshi ;
Bianchi, Giada ;
Hu, Yiguo ;
Cirstea, Diana ;
Santo, Loredana ;
Tai, Yu-Tzu ;
Nahar, Sabikun ;
Zheng, Mei ;
Bandi, Madhavi ;
Carrasco, Ruben D. ;
Raje, Noopur ;
Munshi, Nikhil ;
Richardson, Paul ;
Anderson, Kenneth C. .
BLOOD, 2010, 115 (25) :5202-5213